BIOTHERAPY INST OF JAPAN has a total of 11 patent applications. Its first patent ever was published in 2011. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals and biotechnology are DNAVEC CORP, GENVEC INC and GENETIC THERAPY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Japan | 2 | |
#4 | United States | 2 | |
#5 | Hong Kong | 1 | |
#6 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Deng Xuewen | 11 |
#2 | Terunuma Hiroshi | 9 |
#3 | Nieda Mie | 9 |
#4 | Terunuma Yutaka | 2 |
#5 | Nieda Yoshie | 2 |
Publication | Filing date | Title |
---|---|---|
US2016075996A1 | Method for producing nk cell-enriched blood preparation | |
WO2012099093A1 | Process for production of nk-cell-enriched blood preparation | |
JP2013081428A | Method for enhancing cd56-positive t cell | |
JP2013071915A | Method for producing nk cell strengthening type blood product | |
EP2535052A1 | Method for producing nk cell enhancement-type blood product |